Peripheral Arterial Disease

Clinical Trial Finder

Many patients with peripheral arterial disease are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Post-revascularization Rehabilitation to Improve Function in Veterans With PAD

Conditions:   Peripheral Arterial Disease;   Intermittent Claudication
Interventions:   Other: Exercise training;   Other: NMES
Sponsor:   VA Office of Research and Development
Recruiting - verified October 2016

Safety and Efficacy Study of VM202 in the Treatment of Chronic Non-Healing Foot Ulcers

Condition:   Foot Ulcer, Diabetic
Interventions:   Genetic: VM202;   Other: Placebo
Sponsor:   ViroMed Co., Ltd. dba VM BioPharma
Not yet recruiting - verified October 2016

Efficacy and Safety of Rivaroxaban in Reducing the Risk of Major Thrombotic Vascular Events in Subjects With Symptomatic Peripheral Artery Disease Undergoing Peripheral Revascularization Procedures of the Lower Extremities

Condition:   Peripheral Artery Disease
Interventions:   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Rivaroxaban-Placebo
Sponsors:   Bayer;   Janssen Research & Development, LLC;   Colorado Prevention Center
Recruiting - verified October 2016

Women's Health Initiative Strong and Healthy Study

Conditions:   Myocardial Infarction;   Stroke;   Cardiovascular Mortality;   Hip Fractures;   Falls;   Mortality;   Venous Thromboembolic Event;   Peripheral Artery Disease
Intervention:   Behavioral: Physical Activity
Sponsors:   Fred Hutchinson Cancer Research Center;   University of California, San Diego;   Stanford University;   National Heart, Lung, and Blood Institute (NHLBI)
Enrolling by invitation - verified October 2016

Patients With Intermittent Claudication Injected With ALDH Bright Cells

Conditions:   Peripheral Artery Disease;   Intermittent Claudication
Interventions:   Biological: ALD-301;   Biological: Placebo (vehicle)
Sponsors:   The University of Texas Health Science Center, Houston;   National Heart, Lung, and Blood Institute (NHLBI);   Aldagen;   Center for Cell and Gene Therapy, Baylor College of Medicine
Active, not recruiting - verified September 2016

Invasive Revascularization or Not in Intermittent Claudication

Condition:   Intermittent Claudication
Interventions:   Procedure: INVASIVE (INV) treatment;   Other: Best medical treatment (BMT)
Sponsors:   Sahlgrenska University Hospital, Sweden;   Göteborg University
Active, not recruiting - verified October 2016

Technical Development of Cardiovascular Magnetic Resonance Imaging

Condition:   Peripheral Artery Disease
Intervention:   Procedure: MRI
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified October 2016